Hospital Updates

SIRIO Launches Two Novel Gummies at CPHI Frankfurt

SIRIO Pharma (SIRIO) – the global nutraceutical contract development and manufacturing organization (CDMO) – launches two new gummies at CPHI Frankfurt (Stand: 91D70). The new products are formulated to help customers meet the growing demand for nutraceuticals that aid with sleep and stress, as well as boost the immune system. Both newly created gummies will form part of […]

Hospital Updates

Novel Damiana Extract For Him and Her

Nutraceutical experts Pharmactive Biotech Products, S.L.U., launches Liboost®, a novel botanical extract of Damiana (Turnera diffusa), as the first formulation to help enhance sexual function in both men and women. Its sexual performance boosting capabilities have been confirmed in a consumer study conducted by the company yielding impressive results. An in vitro study also supports […]

Press Announcements

Novel Low-Dose Ashwagandha Extract Helps Improve Immunity

Results from a new human study provide support for the immune health capacity attributed to Arjuna Natural Ltd.’s branded high-potency ashwagandha (Withania somnifera) extract, Shoden®. While recent studies demonstrated strong support for ashwagandha’s traditional use in mitigating symptoms of anxiety and stress, and helping to support natural energy, this latest research focused on immunomodulatory effects […]

Drug Updates

Boehringer Ingelheim Acquires Abexxa Biologics to Further Expand its Research Efforts in Cancer Immunology and Novel Immunotherapeutic Approaches

Boehringer Ingelheim today announced the acquisition of Abexxa Biologics Inc., a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology research to develop the next generation of precision medicines designed to revolutionize cancer treatments. The acquisition will allow Boehringer Ingelheim to access Abexxa’s expertise in targeting cancer-specific proteins that are located […]

Drug Updates

Aragen Announces Partnership with Skyhawk Therapeutics, Aimed at Developing Novel Small Molecule Therapeutics that Correct RNA Expression

Aragen Life Sciences (formerly, GVK BIO), a leading Contract Research and Development Organization (CRDO), headquartered out of Hyderabad, India, announced that it has been selected by Skyhawk Therapeutics, a leader in the development of small molecule therapeutics that correct RNA expression, as its partner in India. Through this collaboration, Aragen will provide Skyhawk with various discovery chemistry and biology service solutions. This partnership is focused on accelerating Skyhawk’s research […]